Description
Stenabolic (SR-9009) + Cardarine (GW-501516) research stack
Stenabolic + Cardarine combines SR-9009, a Rev-Erb agonist, with GW-501516, a PPAR-δ agonist.
Product details
| Compound | Stenabolic (SR-9009) and Cardarine (GW-501516) |
|---|---|
| Class | Two-compound research stack |
| Form | Tablets; Capsules; Transdermal Liquid; Injectables |
| Strength | 20mg per tablet/27ct/540mg; 20mg per tablet/54ct/1080mg; 20mg per capsule/60ct/1200mg; 60ml/34mg per ml = 2g Total; 10ml/64mg per ml = 640mg Total |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- SR-9009: Rev-Erb and circadian research.
- GW-501516: PPAR-δ signalling.
- Metabolic research: oxidative gene programmes.
Research interest does not establish a proven effect in humans.
Regulatory status
This is a research blend. None of its components is approved for human use in this form, and it is supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from heat and light.
Related research products
S-23 + YK-11 + LGD-4033 + 5a Hydroxy Laxogenin Transdermal · T3 Liothyronine Sodium + SR-9011 + Yohimbine · T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal · All transdermals
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.